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Background and aim: Plasmid-mediated colistin resist-
ance mechanisms have been identified worldwide in 
the past years. A multiplex polymerase chain reac-
tion (PCR) protocol for detection of all currently known 
transferable colistin resistance genes (mcr-1  to  mcr-
5, and variants) in  Enterobacteriaceae  was devel-
oped for surveillance or research purposes. Methods: 
We designed four new primer pairs to amplify  mcr-
1,  mcr-2,  mcr-3  and  mcr-4  gene products and used 
the originally described primers for  mcr-5  to obtain 
a stepwise separation of ca 200 bp between ampli-
cons. The primer pairs and amplification conditions 
allow for single or multiple detection of all currently 
described  mcr  genes and their variants present 
in  Enterobacteriaceae. The protocol was validated 
testing 49 European  Escherichia coli  and  Salmonella 
isolates of animal origin.  Results:  Multiplex PCR 
results in bovine and porcine isolates from Spain, 
Germany, France and Italy showed full concordance 
with whole genome sequence data. The method was 
able to detect  mcr-1, mcr-3 and  mcr-4  as singletons 
or in different combinations as they were present in 
the test isolates. One new  mcr-4  variant,  mcr-4.3, 
was also identified.  Conclusions:  This method allows 
rapid identification of mcr-positive bacteria and over-
comes the challenges of phenotypic detection of 
colistin resistance. The multiplex PCR should be par-
ticularly interesting in settings or laboratories with 
limited resources for performing genetic analysis as 
it provides information on the mechanism of colistin 
resistance without requiring genome sequencing.
Introduction 
Colistin belongs to the antimicrobial class desig-
nated polymyxins which originates from the organ-
ism  Paenibacillus polymyxa. This class consists of 
polymyxins A, B, C, D and E, of which only colistin 
(polymyxin E) and polymyxin B are used in clinical 
practice [1]. Colistin has been widely used in veteri-
nary medicine in Asian, European and North American 
countries but human use was restricted due to its 
neuro- and nephrotoxicity [2-4]. In the past decade, 
emergence of multidrug-resistant Gram-negative bac-
teria (such as Enterobacteriaceae, Pseudomonas aerug-
inosa and Acinetobacter baumannii) led to an increase 
of colistin administration as a last resort antibiotic 
for human infections [5]. Prior to the detection of the 
plasmid-mediated resistance gene mcr-1, resistance to 
colistin in  Enterobacteriaceaehad only involved chro-
mosomal mutations, including mutations in the pmrA/
pmrB  two-component system that regulate synthesis 
and structure of the lipopolysaccharide [6].
Global surveillance of plasmid-mediated colistin resist-
ance is hindered by the technical difficulties of phe-
notypic tests owed to particular interactions of the 
drug with reagents or materials and resulting from 
its specific molecular structure. The main problems 
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associated with phenotypic testing are the (i) irregu-
lar diffusion of colistin in agar media, (ii) interaction 
with cations in media and (iii) possible adsorption of 
the antibiotic to certain laboratory materials, which 
make the agreement of results between replicated 
testing and between laboratories difficult. Disk diffu-
sion, agar dilution and Etest strips methods cannot 
be used to perform colistin susceptibility testing, and 
there is yet not enough information available regarding 
automated methods to reach a significant conclusion 
about their sensitivity [1,7]. Thus to date, only deter-
mination of minimum inhibitory concentration (MIC) 
by broth microdilution is recommended in technical 
guidance documents by the European Committee on 
Antimicrobial Susceptibility Testing (EUCAST) and the 
Clinical and Laboratory Standards Institute (CLSI) [8,9].
The first plasmid-mediated colistin resistance gene 
was identified in an Escherichia coli strain from a pig in 
China and also found to be present in other Escherichia 
coli  and  Klebsiella pneumoniae  isolates in samples 
from both animal and human origin, collected between 
2011 and 2014 [4]. The mcr-1 gene (KP347127) encodes 
a phosphoetanolamine transferase that alters the lipid 
A in the lipopolysaccharide of the bacterial outer mem-
brane. This reduces the attachment of colistin and 
therefore prevents cell lysis. Although this mechanism 
has only recently been discovered there are reports of 
isolates recovered in 1980 harbouring the mcr-1 gene, 
but most cases refer to isolates collected since 
2009 [10]. After the first detection, additional 
four  mcr  genes were described:  mcr-2  (LT598652) 
was found in  E. coli  from animal sources in Belgium 
[11],  mcr-3  (KY924928) in  E. coli  from pigs in China 
[12],  mcr-4  (MF543359) in  E.  coli  and  Salmonella 
enterica  serovar Typhimurium from pigs in Italy, 
Spain and Belgium [13] and  mcr-5  (KY807921) 
in  Salmonella  Paratyphi B dTa + from poultry in 
Germany [14]. Variants of  mcr-1,  mcr-3  and  mcr-4  [15-
18] as well as co-occurrence of  mcr-1  and  mcr-3  have 
been observed in Enterobacteriaceae [19,20].
Even though  mcr  genes have been more prevalent in 
animal and food isolates than in human strains, multiple 
cases of human infection by strains harbouring  mcr-
1,  mcr-3  or  mcr-4  have been observed [15,18,21]. 
Worldwide, over 100  Enterobacteriaceae  strains 
harbouring  mcr  have been recovered from human 
hosts, mostly  E. coli  strains, in patients originating 
from, or who had recently travelled to, Asian countries 
[15]. This includes the first mcr-1 description by Liu et al. 
who identified 16 mcr-1-positive E. coli and K. pneumo-
niae  clinical strains [4]. More recently,  mcr-1  and  mcr-
1.2 were described in one  E. coli  and one  K. 
pneumoniae  strain from infected humans in Denmark 
[22] and Italy [23], respectively. Three additional  E. 
coli strains carrying the mcr-1 gene were found in faecal 
samples of Dutch travellers [24] and a study of pilgrims 
travelling to Mecca revealed the gene in 10 E. coli and 
one  K. pneumoniae  strains [25]. These findings repre-
sent a snapshot of the cases so far described of mcr-1 i
n Enterobacteriaceae of human origin and illustrate the 
global spread of bacteria carrying  mcr-1. In Denmark, 
one E. coli and 10 Salmonella clinical strains collected 
between 2009 and 2017 were found to harbour mcr-3, 
six of which were present in people reporting previ-
ous travel to Thailand or Vietnam [17,19]. In Italy, mcr-
4-positive Salmonella  strains have been isolated from 
two humans with gastroenteritis [18].
The discovery of plasmid-mediated colistin resistance 
has raised international concern as the spread of this 
resistance might hamper the efficacy of colistin in 
humans, although the full clinical relevance has not yet 
been determined. Plasmid-mediated resistance genes 
have the potential to be further transmitted and spread 
globally, including to and within regions with already 
high levels of antimicrobial resistance where multidrug-
resistant bacteria represent a public health concern. 
This can lead to the emergence of colistin-resistance 
in already multidrug-resistant bacteria, for which colis-
tin represents a last-resort antibiotic, and compromise 
antibiotic treatment. Thus, human infections for which 
therapeutic options have been depleted could occur in 
nosocomial settings.
Figure 
Multiplex PCR for detection of mcr-1, mcr-2, mcr-3, mcr-4 
and mcr-5, European Union Reference Laboratory for 
Antimicrobial Resistance (EURL-AR) in the context of 
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Visualisation of the bands on an agarose (1.5%) gel for the five 
positive control strains. GeneRuler 100 bp Plus DNA Ladder 
(Thermo Fisher Scientific, Waltham, Massachusetts, United States) 
was used as molecular size marker and the size of each amplicon 
is indicated at the side. Mix corresponds to results obtained with a 
5 µL mixture of DNA from all five control strains. Neg. corresponds 
to the blank negative control.
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Considering (i) the global concerns, (ii) the unreliabil-
ity of most phenotypic methods for colistin suscepti-
bility testing for surveillance purposes, and (iii) the 
limited availability of whole genome sequencing (WGS) 
technology in some settings or laboratories with a 
lack of adequate resources, we aimed to develop and 
validate a method that enables screening of relevant 
isolates in a cheap, rapid and efficient way to identify 
those possibly harbouring plasmid-mediated colistin 
resistance genes and meriting further characterisa-
tion. Here, we describe a multiplex PCR protocol that 
detects  mcr-1, mcr-2, mcr-3, mcr-4  and  mcr-5  genes 
rapidly and reliably for surveillance purposes and 
epidemiological research, particularly in food, animal 
and environmental samples.
Methods 
The multiplex PCR method development
To allow fast and simultaneous detection of all the 
currently described  mcr  genes and their variants 
and improve visualisation by gel electrophoresis, we 
focused on conventional block multiplex PCR technique. 
It was chosen because of its simplicity that enables it 
to be used in all laboratories and settings with limited 
laboratory resources, limited or no access to WGS, and 
in situations where a rapid answer is desired.
The primers for  mcr-5  were those described in the 
original study whereas the primers for  mcr-1  (320 
bp), mcr-2 (715 bp), mcr-3 (929 bp) and mcr-4 (1116 bp) 
were designed in this study (Table 1) in order to obtain 
sequential amplicons with a stepwise size separation 
of ca 200 bp and allow easy visualisation of bands on 
agarose gels.
As determined by the Basic Local Alignment Search 
Tool (BLAST) at the National Center for Biotechnology 
Information (NCBI), these primers amplify 
all  mcr  variants detected in  Enterobacteriaceae  to 
date:  mcr-1.2  (KX236309),  mcr-1.3  (KU934208),  mcr-
1.4  (KY041856),  mcr-1.5  (KY283125),  mcr-
1.6  (KY352406),  mcr-1.7  (KY488488),  mcr-
1.8(KY683842),  mcr-1.9  (KY964067.1),  mcr-
1.11  (KY853650.1),  mcr-1.12  (LC337668.1),  mcr-1.xx  (a 
new  mcr-1  variant, submitted for publication but not 
yet definitely named), mcr-3.2  (NPZH01000177.1), mcr-
3.4  (FLXA01000011.1),  mcr-3.5  (MF463699.1), 
mcr-3.10  (MG214533.1),  mcr-3.11  (MG489958.1),  mcr-
4.2 (MG581979) and mcr-5.xx (a new mcr-5variant, sub-
mitted for publication but not yet definitely named). The 
remaining variants known so far, mcr-1.10(MF176238.1), 
mcr-2.2  (NG_055496.1), mcr-3.3  (MF495680.1), 
mcr-3.6  (MF598076.1), mcr-3.7  (MF598077.1), mcr-
3.8(MF598079.1) and  mcr-3.9  (MF598080.1) have not 
been reported in Enterobacteriaceae, having only been 
found in  Moraxella  spp. and  Aeromonas  spp.. A full 
overview of mcr genes and their variants known to date 
can be found in the Supplement. BLAST analysis also 
revealed neither interaction between primer pairs nor 
unspecific binding to other genes.
The original reference strains for  mcr-2  (E. coli  KP37) 
and  mcr-5  (Salmonella  Paratyphi B dTa + 13-SA01718), 
and strains available at the Technical University of 
Denmark in Lyngby for  mcr-1  (E. coli  2012–60–1176–
27),  mcr-3  (E. coli2013-SQ352) and  mcr-4  (E. coli 
DH5α with the entire mcr-4 gene cloned in pCR2 vector) 
were used as positive controls in the multiplex PCR 
(Table 1). DNA templates were obtained from overnight 
agar cultures by thermal cell lysis. Each PCR reaction 
consisted of 12.5 µL DreamTaq Green PCR Master Mix 
(Thermo Fisher Scientific, Waltham, Massachusetts, 
United States), 5.5 µL of nuclease-free water, 0.5 µL 
of each of the 10 primers solutions (10 µM), and 2 µL 
DNA lysate. Running conditions were: 1 cycle of dena-
turation at 94 °C for 15 min, followed by 25 cycles of 
denaturation at 94 °C for 30 s, annealing at 58 °C for 90 
s and elongation at 72 °C for 60 s, and a final cycle of 
elongation at 72 °C for 10 min. The amplification was 
visualised by electrophoresis using 1.5% agarose gel at 
130V followed by staining in ethidium-bromide.
Table 1
Primers and positive control strains used for multiplex PCR for detection of mcr-1, mcr-2, mcr-3, mcr-4 and mcr-5 genes
Primer name Sequence (5’-3’) Target gene
Size 
(bp) Positive control strain Reference
mcr1_320bp_fw AGTCCGTTTGTTCTTGTGGC
mcr-1 320 Escherichia coli 2012–60–1176–27 [22] This study
mcr1_320bp_rev AGATCCTTGGTCTCGGCTTG
mcr2_700bp_fw CAAGTGTGTTGGTCGCAGTT
mcr-2 715 E. coli KP37 [11] This study
mcr2_700bp_rev TCTAGCCCGACAAGCATACC
mcr3_900bp_fw AAATAAAAATTGTTCCGCTTATG
mcr-3 929 E. coli 2013-SQ352 This study
mcr3_900bp_rev AATGGAGATCCCCGTTTTT
mcr4_1100bp_fw TCACTTTCATCACTGCGTTG
























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































An internal amplification control was not used due to 
the incompatibility with DreamTaq Green PCR Master 
Mix, which contains a DNA polymerase synthesised 
in  E. coli  and thus yields amplicons when using 16S 
rRNA primers.
Test isolates for validation of the multiplex 
PCR
To validate the multiplex PCR, 49 isolates from four 
European countries were used. These isolates were 
collected within the framework of the European 
Monitoring of Antimicrobial Resistance pertaining to the 
Commission Implementing Decision 2013/652/EU [26]. 
They were analysed at the European Union Reference 
Laboratory for Antimicrobial Resistance (EURL-AR) 
in the context of animal health and food safety, in 
accordance with the EURL-AR/European Food Safety 
Authority (EFSA) confirmatory testing, that consists of 
MIC determination by broth microdilution and WGS by 
Illumina Hi-Seq (Illumina, Inc., San Diego, California, 
United States) (European Nucleotide Archive project 
PRJEB21546). The confirmatory testing represents a 
random snapshot of submitted unusual phenotypes 
within each participating country based on selective 
criteria from EFSA.
Results 
Isolates collected in 2016 from Spain (n = 19), Germany 
(n = 16), France (n = 10) and Italy (n = 4) were selected 
for this study due to the diverse colistin resistance 
profiles found by WGS in these countries. Forty-two 
isolates were  E. colifrom porcine (n = 20) and bovine 
(n = 22) sources (including caecum and meat samples) 
and seven isolates were Salmonella spp. from porcine 
(n = 5) and bovine (n = 2) sources.
The multiplex PCR protocol specifically amplified the 
fragments of the five mcr genes. Amplicon size ranged 
from 320 bp (mcr-1) to 1,644 bp (mcr-5) (Figure). 
No interference between primer pairs and no unspe-
cific products were observed. Analysing the validation 
set, the method detected  mcr-1,  mcr-3  and  mcr-4  as 
singletons and in different combinations (Table 2).
Validation test and comparison with WGS data
The validation test set revealed eight colistin-resist-
ant E. coli isolates (MIC 4 – 8 mg/L), five from bovine and 
three from porcine origin, harbouring the mcr-1 gene or 
one of its variants. An additional E. coli  isolate from a 
pig phenotypically classified as borderline susceptible 
(colistin MIC of 2 mg/L), on repeated testing at two lab-
oratories also harboured the mcr-1 gene. The multiplex 
PCR also yielded mcr-1  in one porcine Salmonella spp. 
isolate with colistin MIC of 8 mg/L. One E. coli  isolate 
of bovine origin with MIC of 4 mg/L harboured 
the  mcr-3  gene. Three isolates, with colistin MIC of 4 
mg/L, harboured the  mcr-4  gene, corresponding to 
two  Salmonella  spp. (one isolated from pig and the 
other from calf) and one porcine E. coli. Co-occurrence 
of  mcr-1  and  mcr-3  was observed in two bovine  E. 
coli isolates with colistin MICs of 4 and 8 mg/L, respec-
tively. One porcine E. coli isolate with colistin MIC of 8 
mg/L harboured both mcr-1 and mcr-4 genes.
The results were 100% concordant with WGS data 
and notably, the multiplex PCR was able to detect 
a novel variant described in this study for the first 
time,  mcr-4.3,  that varies in one amino-acid from the 
original  mcr-4  encoded protein (Table 2). The genome 
of the isolate harbouring  mcr-4.3  (Salmonella  enter-
ica  serovar Kedougou 151570) is deposited in ENA 
with the accession number ERS1801979. Additionally, 
the multiplex PCR also detected a  mcr-4  gene with a 
deletion in nt 441 that alters the reading frame and 
introduces a premature stop codon. There was one  E. 
coli isolate presenting phenotypic resistance to colistin 
(MIC = 8 mg/L) not due to the presence of  mcr  genes, 
but instead attributed to the mutations  pmrB  D283G/
Y358N in the  pmrA/pmrB  two-component system as 
determined by analysis of WGS data (Table 2).
Discussion 
The multiplex PCR reaction showed 100% specificity 
(no unpredicted amplification products) and 100% sen-
sitivity (all of the predicted products were visualised in 
agarose gel) for the validation set, according to WGS 
data.
One notable finding was the detection of  mcr-1  in 
one  E. coli  isolate classified as wildtype (susceptible) 
(colistin MIC of 2 mg/L). Preliminary results from other 
studies revealed similar findings of  E. coli  isolates, 
particularly from poultry, with MIC of 2 mg/L and 
carrying the mcr-1 gene, collected in Denmark (data not 
shown) and Poland (Dariusz Wasyl, National Veterinary 
Research Institute, Puławy, Poland, personal communi-
cation, January 2018). These findings seem to indicate 
that there is a need to review of the established epide-
miological cut-off value for colistin. Also based on the 
discovery of a new mcr-4 variant (mcr-4.3), it becomes 
clear that colistin resistance is not yet fully uncovered 
although our knowledge is evolving rapidly, filling the 
gaps that compromise the prevention and control of 
multidrug-resistant bacteria.
Another observation of interest was the detection of 
two  pmrA/pmrB  point mutations in one colistin-resist-
ant isolate, which reveals a need to further investigate 
and characterise this two-component system in order 
to accurately predict which mutations lead to pheno-
typic colistin resistance. Taking into account that the 
mutations found in this isolate are not consistently 
associated with a resistant phenotype we cannot con-
firm, without further analysis, if they represent the 
underlying mechanism of colistin resistance for this 
isolate [27,28].
Although the presented multiplex PCR does not allow 
identification of the specific variants and detects non-
functional genes, it still provides valuable information 
for surveillance purposes as well as for research. The 
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results of the multiplex PCR also allow the selection 
of isolates for further studies based on genomic epi-
demiology, focusing on characterisation of mcr genes, 
their mobilisation mechanisms and the plasmids they 
are harboured on. While the multiplex PCR has not 
yet been validated on human strains, it is expected 
to provide the same sensitivity and specificity as for 
animal isolates. The vast majority of  mcr  genes are 
located on transferable plasmids that are not restricted 
to reservoirs or hosts. Similarly, we expect that this 
multiplex PCR design will maintain its usefulness 
should new gene variants among  mcr-1  to  mcr-5  be 
detected in  Enterobacteriaceae, taking into account 
that the chance of variations in the primer annealing 
positions should be small and no such variations have 
been observed so far. A great advantage of this method 
is the ability to detect  mcr  genes in phenotypically 
susceptible bacteria, allowing it to be used as a 
screening technique for isolates recovered from human 
and animal sources. We believe future efforts should 
include the screening of large pools of borderline sus-
ceptible  Enterobacteriaceae  in order to understand if, 
and how, the epidemiological cut-off value for colistin 
should be reviewed.
Although an internal amplification control was not 
used in this study, it should be possible to use a dif-
ferent reaction mix containing another DNA polymer-
ase in order to allow the addition of 16S rRNA primers 
to obtain an internal reaction control. We encourage 
researchers to adapt the PCR reaction to their specific 
needs.
This screening method can provide a useful and accu-
rate description of colistin resistance in  Enterobacte
riaceaecollections, particularly when used in connec-
tion with MIC susceptibility testing. The protocol and 
standard operating procedure are freely available at 
the EURL-AR website (https://www.eurl-ar.eu/). The 
intended use for this multiplex PCR is as part of the 
surveillance workflow, to screen colistin-resistant 
and borderline susceptible isolates after initial MIC 
determination by the standard broth dilution method. 
Colistin MIC determination allows classification of iso-
lates as susceptible, borderline susceptible or resistant 
and, subsequently, the isolates determined borderline 
susceptible and resistant (MIC ≥ 2 mg/L) can be sub-
jected to the multiplex PCR to provide further insight 
into the underlying resistance mechanism and poten-
tially reveal the presence of the known mcr genes. For 
an initial surveillance analysis we do not recommend 
to perform the multiplex PCR before MIC determina-
tion, since it could lead to overlooking colistin resist-
ant isolates with other underlying mechanisms of 
resistance. The method can, however, be used on its 
own if the research is focused, for example, on plasmid 
dissemination or  mcr  genes’ epidemiology. Advanced 
investigations could be conducted according to 
available procedures and surveillance/research goals, 
and would ideally involve WGS of the bacterial genome, 
even though it may not be easily accessible in some 
laboratories or countries, in particular, low and mid-
dle income countries (LMIC). Colistin resistant bacteria 
lacking any of the currently known  mcr  genes should 
be screened for other mechanisms of resistance, such 
as mutations in the pmrA/pmrBsystem, new mcr genes 
or variants, or even presently unknown mechanisms.
Future prospects include validation of the multiplex 
PCR for human clinical strains, to assure that the proto-
col follows the principles of the One Health perspective 
and can be used to directly screen human, veterinary 
and food bacteria. Other prospects are to clone  mcr-
1, mcr-2, mcr-3  and  mcr-5  amplicons into TA-cloning 
vectors (Thermo Fisher Scientific) in order to obtain 
non-pathogenic and easy to handle control strains, 
and be able to confirm and update the protocol con-
tinuously as new variants are being detected.
In conclusion, we developed a multiplex PCR 
that rapidly detects all  mcr  genes described 
in  Enterobacteriaceae  to date. The multiplex PCR 
method is critical for epidemiological surveillance 
and antimicrobial resistance investigation, especially 
in settings where laboratory resources and access to 
WGS are limited, and where plasmid-mediated colistin 
resistance may threaten the effectiveness of available 
antimicrobials.
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